Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia

Blood

Volumn 89, Issue 4, 1997, Pages 1405-1412

  Inoue, Kazushi ^b   Ogawa, Hiroyasu ^b   Sonoda, Yoshiaki ^b   Kimura, Takafumi ^b   Sakabe, Hideaki ^b   Oka, Yoshihiro ^b   Miyake, Seigou ^b   Tamaki, Hiroya ^b   Oji, Yusuke ^b   Yamagami, Tamotsu ^b   Tatekawa, Toyoshi ^b   Soma, Toshihiro ^b   Kishimoto, Tadamitsu ^b   Sugiyama, Haruo ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; HLA DR3 ANTIGEN;

ARTICLE; BONE MARROW CELL; CELL SELECTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; LEUKEMOGENESIS; NEPHROBLASTOMA; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

EID: 0031048878     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.4.1405     Document Type: Article

References (42)

1. Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE: Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol Cell Biol 11:1707, 1991
2. Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, Fletcher J, Shipman R, Rheinwald J, Demetri G, Griffin J, Minden M, Housman DE, Haber DA: The Wilms tumor gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat Genet 4:415, 1993
3. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT-1 is required for early kidney development. Cell 74:679, 1993
4. Miwa H, Beran M, Saunders GF: Expression of the Wilms tumor gene (WT1) in human leukemias. Leukemia 6:405, 1992
5. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K, Kyo T, Dohy H, Nakauchi H, Ishidate T, Akiyama T, Kishimoto T: WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84:3071, 1994
6. Inoue K, Ogawa H, Yamagami T, Soma T, Tani Y, Tatekawa T, Oji Y, Tamaki H, Kyo T, Dohy H, Hiraoka A, Masaoka T, Kishimoto T, Sugiyama H: Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. Blood 88:2267, 1996
7. Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, Hirata M, Kudoh T, Akiyama T, Murakami A, Maekawa T, Kishimoto T: Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: Implications for the involvement of WT1 in leukemogenesis. Blood 87:2878, 1996
8. Sonoda Y, Kuzuyama T, Tanaka S, Yokota S, Maekawa T, Clark SC, Abe T: Human interleukin-4 inhibits proliferation of megakaryocyte progenitor cells in culture. Blood 81:624, 1993
9. + highly purified blood progenitors expressing HLA-DR or different levels of c-kit protein. Blood 84:4099, 1994
10. Inoue K, Sugiyama H, Ogawa H, Yamagami T, Azuma T, Oka Y, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K, Kyo T, Dohy H, Hara J, Kanamaru A, Kishimoto T: Expression of the interleukin-6 (IL-6), IL-6 receptor, and gp130 genes in acute leukemia. Blood 84:2672, 1994
11. Ema H, Suda T, Miura Y, Nakauchi H: Colony formation of clone-sorted human hematopoietic progenitors. Blood 75:1941, 1990
12. +). Exp Hematol 19:680, 1991
13. Bender JG, Unverzagt KL, Walker DE, Lee W, Van Epps DE, Smith DH, Stewart CC, To LB: Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 77:2591, 1991
14. Serke S, Säuberlich S, Abe Y, Huhn D: Analysis of CD34-positive hemopoietic progenitor cells from normal human adult peripheral blood: Flow-cytometrical studies and in-vitro colony (CFU-GM, BFU-E) assays. Ann Hematol 62:45, 1991
15. + hematopoietic cells. Exp Hematol 20:24, 1992
16. Kinniburgh D, Russell NH: Comparative study of CD34-positive cells and subpopulations in human umbilical cord blood and bone marrow. Bone Marrow Transplant 12:489, 1993
17. + cell populations derived from human umbilical cord blood using flow cytometry and cDNA-polymerase chain reaction. Blood 83:2103, 1994
18. - progenitor cells. Blood 77:1218, 1991
19. Terstappen LWMM, Buescher S, Nguyen M, Reading C: Differentiation and maturation of growth factor expanded human hematopoietic progenitors assessed by multidimensional flow cytometry. Leukemia 6:1001, 1992
20. - progenitor cells in long-term cultures and semisolid assays. Blood 81:2916, 1993
21. Moore MAS, Broxmeyer HE, Sheridan APC, Meyers PA, Jacobsen N, Winchester RJ: Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells. Blood 55:682, 1980
22. Keating A, Powell J, Takahashi M, Singer JW: The generation of human long-term marrow cultures from marrow depleted of Ia (HLA-DR) positive cells. Blood 64:1159, 1984
23. Brandt J, Baird N, Lu L, Srour E, Hoffman R: Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. J Clin Invest 82:1017, 1988
24. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM: Charcterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74:1563, 1989
25. + cells. Blood 74:1287, 1989
26. Verfaillie C, Blakolmer K, McGlave P: Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 172:509, 1990
27. Udomsakdi C, Lansdorp PM, Hogge DE, Reid DS, Eaves AC, Eaves CJ: Characterization of primitive hematopoietic cells in normal human peripheral blood. Blood 80:2513, 1992
28. Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S-I, Kunisada T, Sudo T, Kina T, Nakauchi H, Nishikawa S-I: Expression and function of c-kit in hematopoietic progenitor cells. J Exp Med 174:63, 1991
29. - bone marrow progenitors and inhibition of response to recombinant human interleukin-3 following exposure to c-kit anitsense oligonucleotides. Blood 78:3186, 1991
30. Papayannopoulou T, Brice M, Broudy VC, Zsebo KM: Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: Functional properties and composite antigenic profile. Blood 78:1403, 1991
31. Ratajczak MZ, Luger SM, DeRiel K, Abrahm J, Calabretta B, Gewirtz AM: Role of the KIT protooncogene in normal and malignant human hematopoiesis. Proc Natl Acad Sci USA 89:1710, 1992
32. Briddell RA, Broudy VC, Bruno E, Brandt JE, Srour EF, Hoffman R: Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor. Blood 79: 3159, 1992
33. Orlic D, Fischer R, Nishikawa S-I, Nienhuis AW, Bodine DM: Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood 82:762, 1993
34. high cells. Blood 82:3283, 1993
35. Laver JH, Abboud MR, Kawashima I, Leary AG, Ashman LK, Ogawa M: Characterization of c-kit expression by primitive hematopoietic progenitors in umbilical cord blood. Exp Hematol 23:1515, 1995
36. Fraizer GC, Patmasiriwat P, Zhang X, Saunders GF: Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow. Blood 86:4704, 1995
37. Menssen HD, Renkl H-J, Rodeck U, Maurer J, Hotter M, Schwartz S, Reinhard R, Thiel E: Presence of Wilms' tumor gene (WT1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 9:1060, 1995
38. Sekiya M, Adachi M, Hinoda Y, Imai K, Yachi A: Downregulation of Wilms' tumor gene (WT1) during myelomonocytic differentiation in HL60 cells. Blood 83:1876, 1994
39. Phelan SA, Lindberg C, Call KM: Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Differ 5:677, 1994
40. King-Underwood L, Renshaw J, Pritchard-Jones K: Mutations in the Wilms' tumor gene WT1 in leukemias. Blood 87:2171, 1996
41. Wu Y-J, Fraizer GC, Saunders GF: GATA-1 transactivates the WT1 hematopoietic specific enhancer. J Biol Chem 270:5944, 1995
42. Shimamoto T, Ohyashiki K, Ohyashiki JH, Kawakubo K, Fujimura T, Iwama H, Nakazawa S, Toyama K: The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia. Blood 86:3173, 1995